Supply of Rabies Vaccine (Human use) - 3346490
The STATE PHARMACEUTICALS CORPORATION OF SRI LANKA in Sri Lanka from Asia region had released this tender for Tenders are invited for Supply of 700,000 Doses of Rabies Vaccine (Human use) 0.5ml/1ml-Inactivated Rabies Vaccine (Human use) (0.5ml/1ml). Each dose 0.1ml to contain at least 7 IU/ml of Rabies antigen as an inactivated freeze-dried powder form. Each vial should be either 0.5ml or 1ml. The Vaccine should be suitable for human use, produced in cell culture. (eg. Primary chickembryo cell culture Rabies Vaccine, Vero Cell rabies Vaccine) The vaccine should comply with the Rabies Vaccine as the Pharmacopoeial requirement of vaccine and biological products. Note: 1.Cold chain monitors or WHO recommended other cold chain monitoring device should be included for each cartoon and the cold chain should be maintained according to the manufacturer's instructions during storage, transport & delivery of vaccine. 2.The following documents should be submitted pre- shipment for each lot of vaccine dispatched. (a). Invoice (b).Certificate of origin (c). Certificate of analysis. (d). Lot release certificate from National control Laboratory (NCL) from country of origin. (e). Summary lot protocols of production procedure & quality control testing. (f). Packing list. (g). Copy of product information leaflet (PIL). These documents should be submitted pre-shipment to the National Control Laboratory for Vaccines (MRI) Sri Lanka. 3.Airway bill & temperature monitoring data should be submitted with the sample submission for lot release to NCL. 4.The product should be only from fresh stocks and should have a minimum of 2/3 of remaining shelf life at the time of delivery at MSD. 5.The vaccine should be stored at a temperature range of 2'C - 8'C & should not be frozen. 6.Each vial should be labelled accordingly indicating both date of manufacture and expiry. 700,000 Doses 700,000 Doses/ August 2024 7.The vaccine should be recommended by WHO for intradermal use / the vaccine should be recommended and registered by the National Regulatory Authority of the manufacturing country or a reference country for intradermal use. 8. For the procurement purpose, single dose will be considered as 0.1ml 9.Each vial should be provided with a suitable sterile diluent (5 vials of vaccine + 5 vial of diluent to be packed in the same box). 10. Immunization record cards should be provided for each vial. Patient information should be provided in Sinhala language for 75% of the consignment and Tamil language for the remain 25% (Template to be obtain from MRI). 11. Director/MSD should be informed two weeks prior to the arrival of vaccine. qty 700,000 doses The amount of Bid Bond: LKR 5,426,540.00 or USD 17,677.00. Bid Bond should be submitted with valid up to 25.03.2024 together with the bid Bid should be valid till 24.02.2024. Nonrefundable Bid Fee Rs. 60,000.00 + Taxes. Bid Evaluation Summary sheets should be submitted with the Bid (Please refer SPC website for more details) Tender Type: DHS Status: Open Closing Date: 29-08-2023 11:00 am Nonrefundable Bid Fee: Rs. 60,000/= + Taxes with tender notice no. DHS/P/M/WW/04/24 published on 19 Jul 2023. The tender expired on 29 Aug 2023. This tender is sourced from Official Website and is eligible for suppliers interested in Vaccines. Interested bidders can obtain further information including complete bid documents or ways to participate by registering on Tender Impulse and referencing via Tender Impulse ID 3346490.
*The deadline for this tender has passed.
Tender Notice No:
DHS/P/M/WW/04/24
Tender Organisation:
STATE PHARMACEUTICALS CORPORATION OF SRI LANKA
Tender Sector:
Tender Service:
Worldwide
Tender Region:
Tender Country:
Tender CPV:
33651600 : Vaccines
Tender Document Type:
Tender Notice
Tender Description:
Tenders are invited for Supply of 700,000 Doses of Rabies Vaccine (Human use) 0.5ml/1ml-Inactivated Rabies Vaccine (Human use) (0.5ml/1ml). Each dose 0.1ml to contain at least 7 IU/ml of Rabies antigen as an inactivated freeze-dried powder form. Each vial should be either 0.5ml or 1ml. The Vaccine should be suitable for human use, produced in cell culture. (eg. Primary chickembryo cell culture Rabies Vaccine, Vero Cell rabies Vaccine) The vaccine should comply with the Rabies Vaccine as the Pharmacopoeial requirement of vaccine and biological products. Note: 1.Cold chain monitors or WHO recommended other cold chain monitoring device should be included for each cartoon and the cold chain should be maintained according to the manufacturer's instructions during storage, transport & delivery of vaccine. 2.The following documents should be submitted pre- shipment for each lot of vaccine dispatched. (a). Invoice (b).Certificate of origin (c). Certificate of analysis. (d). Lot release certificate from National control Laboratory (NCL) from country of origin. (e). Summary lot protocols of production procedure & quality control testing. (f). Packing list. (g). Copy of product information leaflet (PIL). These documents should be submitted pre-shipment to the National Control Laboratory for Vaccines (MRI) Sri Lanka. 3.Airway bill & temperature monitoring data should be submitted with the sample submission for lot release to NCL. 4.The product should be only from fresh stocks and should have a minimum of 2/3 of remaining shelf life at the time of delivery at MSD. 5.The vaccine should be stored at a temperature range of 2'C - 8'C & should not be frozen. 6.Each vial should be labelled accordingly indicating both date of manufacture and expiry. 700,000 Doses 700,000 Doses/ August 2024 7.The vaccine should be recommended by WHO for intradermal use / the vaccine should be recommended and registered by the National Regulatory Authority of the manufacturing country or a reference country for intradermal use. 8. For the procurement purpose, single dose will be considered as 0.1ml 9.Each vial should be provided with a suitable sterile diluent (5 vials of vaccine + 5 vial of diluent to be packed in the same box). 10. Immunization record cards should be provided for each vial. Patient information should be provided in Sinhala language for 75% of the consignment and Tamil language for the remain 25% (Template to be obtain from MRI). 11. Director/MSD should be informed two weeks prior to the arrival of vaccine. qty 700,000 doses The amount of Bid Bond: LKR 5,426,540.00 or USD 17,677.00. Bid Bond should be submitted with valid up to 25.03.2024 together with the bid Bid should be valid till 24.02.2024. Nonrefundable Bid Fee Rs. 60,000.00 + Taxes. Bid Evaluation Summary sheets should be submitted with the Bid (Please refer SPC website for more details) Tender Type: DHS Status: Open Closing Date: 29-08-2023 11:00 am Nonrefundable Bid Fee: Rs. 60,000/= + Taxes
Tender Bidding Type:
Tender Document:
- 1 week to go
- 15 Days to go
- More than 15 days to go
Get A Callback Within 24 Hours
Fill form below to get callback from Tender Experts.
Explore More Vaccines Tenders in Sri Lanka, Asia, and Worldwide
Looking for more tenders like this one in Vaccines? With over 11 million global procurement opportunities and new tenders added daily, Tender Impulse is your gateway to international and local contracting success. Whether you're targeting the Healthcare & Medical sector in Sri Lanka, or expanding across regions, we provide live, accurate, and relevant updates every day.
Our platform sources tenders from:
- National and local government portals
- International development and funding agencies
- Municipal corporations and state authorities
- NGOs, education ministries, and public-private partnerships
Daily Tender Updates Across 190+ Countries
Every day, we add hundreds of new RFPs, RFQs, EOIs, and contract awards across multiple sectors and geographies. This tender from Sri Lanka is just a sample of what's available right now.
Tender Impulse covers:
- Public procurement tenders
- International development projects
- Local municipal bids
- Private and PPP contracts
- Framework agreements and supply tenders
Search Smarter with CPV and Industry Matching
Each listing is categorized using CPV codes like 33651600, enabling precise filtering. Search by:
- Tender type: RFP, RFQ, EOI, GPN, Contract Awards
- Location: Sri Lanka, Asia, or global
- Industry: Healthcare & Medical
- Deadline and issue date
- Issuing organization or funding agency
Opportunities in Every Industry and Region
While you're viewing a tender in Sri Lanka, Tender Impulse offers access to tenders across:
- Asia, Europe, Africa, the Americas, and Oceania
- Defence, Energy, Healthcare, Construction, Education, IT, Agriculture, and more
- All CPV categories—from consultancy to infrastructure
Tools to Help You Succeed
Tender Impulse provides more than listings:
- Custom email alerts by CPV and location
- Downloadable bid documents and submission support
- Registration guidance and compliance tools
- Translation support for non-English tenders
- Proposal writing tips and examples
Stay Ahead with Real-Time Updates
Thousands of new tenders are added daily-across countries, sectors, and CPV codes. With Tender Impulse, you gain strategic insight, timely alerts, and a competitive edge.
Request a free live demo now to unlock tenders customized to your Healthcare & Medical, Sri Lanka, and Vaccines categories.
Common Questions About This Tender
-
Who has issued this tender, and what is it for?
The tender has been issued by STATE PHARMACEUTICALS CORPORATION OF SRI LANKA in Sri Lanka. Such a type of tender falls under Vaccines, within the Healthcare & Medical Tenders sector, and is listed on Tender Impulse under notice number DHSPMWW0424.
-
What are the key dates for this tender?
The notice was published on 19 Jul 2023 and submissions close on 29 Aug 2023. Late bids are rarely accepted in public procurement, so aim to have your documents ready several days before the closing date.
-
Which CPV codes apply to this tender?
It is classified under CPV codes 33651600, which correspond to Vaccines. If your company supplies these products or services, these are the codes to save in your alert profile so no matching tender passes you by.
-
Can I submit my bid for this tender to Tender Impulse?
No - and this matters. Tender Impulse is a tender aggregation and alert service: we collect procurement notices from official sources around the world and list them in one place. We do not receive, forward or evaluate bids. Your bid for this tender must be submitted directly to STATE PHARMACEUTICALS CORPORATION OF SRI LANKA, using the method described in the original tender document, before 29 Aug 2023. Tender Impulse provides complete assistance in submitting all bids posted on its website.
-
How do I get the bid documents and participation details?
Request a live demo on Tender Impulse and our tender experts will walk you through this listing, share the available documents, and explain how to submit your bid to STATE PHARMACEUTICALS CORPORATION OF SRI LANKA. Subscribers also receive help with registration requirements and, where needed, translation of non-English notices - but the submission itself always goes from you to the buyer.
-
How can I find more tenders like this in Sri Lanka?
There are currently 2812 live tenders of 85313 total tenders from Sri Lanka on Tender Impulse. You can browse them on our Sri Lanka tenders page, or save a search combining Sri Lanka with CPV codes {full_cpv_codes} - we will then email you every new match on the day it is published.
-
How to prepare for this bid?
Suppliers must verify technical specifications, the delivery schedules and any other intrinsic details as provided in the complete bid documents before deciding to submit their bids. All necessary certifications and supplier registrations must be undertaken before participation.
-
Is this tender beneficial for me?
The procurement is applicable to companies in the Vaccines and related industries. If you belong to this industry, you can review the technical documents before assessing your relevance to your company.
-
What is the Procurement trend for Supply of Rabies Vaccine (Human use)?
The public procurement trends for Supply of Rabies Vaccine (Human use) can be assessed by viewing historical data and buying patterns for this product. Subscribed members can view and even download reports of tenders released in the past for their market research. This shall allow them to carefully prepare a compelling bid.
Latest Tenders by Region
Latest Tenders by Sector
Latest Tenders by Country
Success
Your action completed successfully.